Thiamphenicol
| Systematic (IUPAC) name | |
|---|---|
| 2,2-dichloro-N-{(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-[4-(methylsulfonyl)phenyl]ethyl}acetamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | none |
| Routes | IV, IM, oral |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half-life | 5.0 hours |
| Excretion | renal |
| Identifiers | |
| CAS number | 15318-45-3 |
| ATC code | J01BA02 QJ51BA02 |
| PubChem | CID 27200 |
| DrugBank | DB08621 |
| ChemSpider | 25315 |
| UNII | FLQ7571NPM |
| KEGG | D01407 |
| ChEBI | CHEBI:32215 |
| ChEMBL | CHEMBL1236282 |
| Chemical data | |
| Formula | C12H15Cl2NO5S |
| Mol. mass | 356.223 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Thiamphenicol (also known as thiophenicol and dextrosulphenidol) is an antibiotic. It is the methyl-sulfonyl analogue of chloramphenicol and has a similar spectrum of activity, but is 2.5 to 5 times as potent. Like chloramphenicol, it is insoluble in water, but highly soluble in lipids. It is used in many countries as a veterinary antibiotic, but is available in China and Italy for use in humans. Its main advantage over chloramphenicol is that it has never been associated with aplastic anaemia.
Thiamphenicol is also widely used in Brazil, particularly for the treatment of sexually transmitted infections and pelvic inflammatory disease.[1]
[edit] References
- ^ Fuchs FD (2004). "Tetraciclinas e cloranfenicol". In Fuchs FD, Wannmacher L, Ferreira MB (eds.) (in Portuguese). Farmacologia clínica: fundamentos da terapêutica racional (3rd ed.). Rio de Janeiro: Guanabara Koogan. pp. 375. ISBN 0-7216-5944-6.
[edit] External links
- Overview at World Health Organization - Food and Agriculture Organization
- Raymond J, Boutros N, Bergeret M (2004). "Role of thiamphenicol in the treatment of community-acquired lung infections". Med Trop (Mars) 64 (1): 33–8. PMID 15224555.
- Marchese A, Debbia E, Tonoli E, Gualco L, Schito A (2002). "In vitro activity of thiamphenicol against multiresistant Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in Italy.". J Chemother 14 (6): 554–61. PMID 12583545.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |